Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and MexicoGlobeNewsWire • 12/28/20
Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 VaccineGlobeNewsWire • 12/17/20
3 COVID-19 Vaccine Stocks That Could Be the Biggest Winners in a Post-Pandemic WorldThe Motley Fool • 12/16/20